Patient Name : MRS.

SIRIKI REVATHI Age : 68 YRS Gender: FEMALE

YH NO : 600090091 Billed on : 19/04/2024 01:42:17PM
Diag.No. : 1694588 Collected on : 19/04/2024 01:48:42PM
IP No. : N/A Received on : 19/04/2024 02:02:00PM
Specimen Type : PLASMA Reported on : 19/04/2024 02:38:59PM
Ref.Doctor : DR.KIRTHI PALADUGU - ORTHOPAEDIC Location : OPD
SURGERY Report Status: FINAL
CLINICAL BIOCHEMISTRY
JOINT PROFILE
Test Result Biological Ref Interval Units
RANDOM PLASMA 89.00 mg/dL
GLUCOSE
>200 - Suggestive of Diabetes mellitus
(Glucose oxidase peroxidase)

DR.ARPITA MISHRA M.D

Consultant Biochemistry

Page 1 of 6
 DEPARTMENT OF LABORATORY MEDICINE

Patient Name : MRS.SIRIKI REVATHI Age : 68 YRS Gender: FEMALE

YH NO : 600090091 Billed on : 19/04/2024 01:42:17PM
Diag.No. : 1694588 Collected on : 19/04/2024 01:48:42PM
IP No. : N/A Received on : 19/04/2024 02:02:00PM
Specimen Type : SERUM Reported on : 19/04/2024 02:38:58PM
Ref.Doctor : DR.KIRTHI PALADUGU - ORTHOPAEDIC Location : OPD
SURGERY Report Status: FINAL
CLINICAL BIOCHEMISTRY
JOINT PROFILE
Test Result Biological Ref Interval Units
BLOOD UREA WITH BUN
BLOOD UREA 36.94 15 - 36 mg/dL
(Urease)
Comments : Elevated levels of urea are found in renal disorders, increase in also seen in extrarenal conditions such as cardiac
failure, burns etc. Increase in also found in post renal conditions such as prostate enlargement etc. Decreased
levels are found in pregnancy.
UREA NITROGEN 17.26 7 - 17 mg/dL
(Calculated)
SERUM ELECTROLYTES
SODIUM 144.00 137 - 145 mmol/L
POTASSIUM 4.86 3.5 - 5.1 mmol/L
CHLORIDE 112.00 98 - 107 mmol/L
(Ion selective Electrode - Direct)
Comments : Hemolysis of red blood cells will cause an erroneous increase in Potassium values. In addition samples that are
not promptly processed may have increased potassium concentrations because of potassium leakage from RBC
when whole blood is stored. Administration of intravenous insulin is associated with a spurious decrease in
potassium levels as insulin shifts potassium intracellularly. Samples taken from IV lines directly can lead to
erroneous values of electrolytes.
CREATININE 1.18 0.52 - 1.04 mg/dL
(Creatinine amidohydrolase)
Comments : Increase in serum creatinine occurs in renal disorders, CHF, shock and also in patient taking aminoglucosides
and penicillins.

------------- END OF TEST REPORT ------

DR.ARPITA MISHRA M.D

Consultant Biochemistry

Typed By : LB9039
Yashoda Healthcare Services Pvt.Ltd, Hitec City, Cyber Towers to JNTU Road, Hyderabad, Telangana-500084, www.yashodahospitals.
Kindly co- relate results with clinical findings. Hitec City

Page 2 of 6
 DEPARTMENT OF LABORATORY MEDICINE

Patient Name : MRS.SIRIKI REVATHI Age : 68 YRS Gender: FEMALE

YH NO. : 600090091 Billed on : 19/04/2024 01:42:17PM
Diag.No. : 1694588 Collected on : 19/04/2024 01:48:42PM
IP No. : N/A Received on : 19/04/2024 02:02:00PM
Specimen Type : WHOLE BLOOD Reported on : 19/04/2024 02:30:41PM
Ref.Doctor : DR.KIRTHI PALADUGU - ORTHOPAEDIC Location : OPD
SURGERY Report Status : FINAL
HAEMATOLOGY
JOINT PROFILE
Test Results Biological Ref Interval Units
ERYTHROCYTE SEDIMENTATION RATE
FIRST HOUR 38.00 0 - 20 mm
(Capillary Photometry)

PROTHROMBIN TIME (PT)

WITH INR
Prothrombin Time Test (PT) 13.1 12 - 14.9 seconds
Mean Normal Prothrombin Time (MNPT) 13.20 seconds
International Normalised Ratio (INR) 0.99 0.8 - 1.1
(Photomechanical clot detection.)
Note : 1. INR is the parameter of choice in monitoring adequacy of oral anitcoagulant therapy : 2.0 - 3.5
Appropriate therapeutic range varies with the disease and treatment intensity.
2. Prolonged INR suggests potential bleeding disorder / bleeding complications.
3. Results should be clinically correlated.
4. Test conducted on citrated plasma.

Recommended therapeutic range for Oral Anticoagulant therapy.

INR 2.0 - 3.0 : Deep Vein Thrombosis, Pulmonary Embolism, Hypercoaguable States, Atrial, Fibrillation,
Dilated Cardiomyopathy, Rhemumatic Mitral Valve Disease.

INR 2.5 - 3.5 : Prosthetic heart valves.

ACTIVATED PARTIAL
THROMOBOPLASTIN TIME
(APTT)
Activated Partial thromboplastin time Test (APTT) 27.5 26.8 - 33.6 seconds

DR.SUKANYA YENNI MD. DR.MALATHI.K M.D

Consultant Pathologist Consultant Pathologist

Page 3 of 6
 DEPARTMENT OF LABORATORY MEDICINE

Patient Name : MRS.SIRIKI REVATHI Age : 68 YRS Gender: FEMALE

YH NO. : 600090091 Billed on : 19/04/2024 01:42:17PM
Diag.No. : 1694588 Collected on : 19/04/2024 01:48:42PM
IP No. : N/A Received on : 19/04/2024 02:02:00PM
Specimen Type : CITRATED PLASMA Reported on : 19/04/2024 02:30:41PM
Ref.Doctor : DR.KIRTHI PALADUGU - ORTHOPAEDIC Location : OPD
SURGERY Report Status : FINAL
HAEMATOLOGY
JOINT PROFILE
Test Results Biological Ref Interval Units
Mean Normal Activated Partial Thromboplastin 30.40 seconds
Time
(Photomechanical clot detection.)
Note : This report is generated from the given sample.
:
HAEMOGRAM
HAEMOGLOBIN 10.00 12 - 15 g/dl
(SLS hemoglobin)
TOTAL RBC COUNT 3.80 3.8 - 4.8 million/cu mm
(Hydrodynamic focusing)
PACKED CELL VOLUME (P C V) 31.90 36 - 46 %
(Cumulative pulse height detection method)
RBC INDICES
(Calculated Parameters)
Mean Corpuscular Volume (M C V) 83.90 83 - 101 fL
Mean Corpuscular Hemoglobin (M C H) 26.30 27 - 32 pg
Mean Corpuscular Hemoglobin Concentration 31.3 31.5 - 34.5 g/dl
(M C H C)
Red Cell Distribution Width (RDW-CV) 13.80 11.6 - 14 %
PLATELET COUNT 2.60 1.5 - 4.1 lakhs/cu mm
(Hydrodynamic focusing)
Mean Platelet Volume (M P V) 9.70 7.5 - 11.5 fL
(Calculated parameter)
TOTAL WBC COUNT 5,580.00 4000 - 10000 cells/cu mm
(Fluorescence Flow cytometry)

DR.SUKANYA YENNI MD. DR.MALATHI.K M.D

Consultant Pathologist Consultant Pathologist

Page 4 of 6
 DEPARTMENT OF LABORATORY MEDICINE

Patient Name : MRS.SIRIKI REVATHI Age : 68 YRS Gender: FEMALE

YH NO. : 600090091 Billed on : 19/04/2024 01:42:17PM
Diag.No. : 1694588 Collected on : 19/04/2024 01:48:42PM
IP No. : N/A Received on : 19/04/2024 02:02:00PM
Specimen Type : EDTA WHOLE BLOOD Reported on : 19/04/2024 02:30:41PM
Ref.Doctor : DR.KIRTHI PALADUGU - ORTHOPAEDIC Location : OPD
SURGERY Report Status : FINAL
HAEMATOLOGY
JOINT PROFILE
Test Results Biological Ref Interval Units
DIFFERENTIAL COUNT
Neutrophils 44.00 40 - 80 %
Lymphocytes 47.00 20 - 40 %
Eosinophils 3.00 1 - 6 %
Monocytes 6.00 2 - 10 %
ABSOLUTE COUNTS
Neutrophil 2,455.20 2000 - 7000 cells/cu mm
Lymphocyte 2,622.60 1000 - 3000 cells/cu mm
Eosinophil 167.40 20 - 500 cells/cu mm
Monocyte 334.80 200 - 1000 cells/cu mm
PERIPHERAL SMEAR
RBC Morphology Normocytic normochromic
WBC Normal in count and distribution
Platelets on Smear Adequate
(Microscopy)
Note : This report is generated from the given sample.
For requirement of scattergrams a requisition may please be sent.

Method : (Capillary Photometry)

------------- END OF TEST REPORT ------------

DR.SUKANYA YENNI MD. DR.MALATHI.K M.D

Consultant Pathologist Consultant Pathologist

Typed By : LB9049
Yashoda Healthcare Services Pvt.Ltd, Hitec City, Cyber Towers to JNTU Road, Hyderabad, Telangana-500084, www.yashodahospitals.com
Kindly co- relate results with clinical findings. Hitec City

Page 5 of 6
 DEPARTMENT OF LABORATORY MEDICINE

Patient Name : MRS.SIRIKI REVATHI Age : 68 YRS Gender: FEMALE

YH NO. : 600090091 Billed on :19/04/2024 01:42:17 PM
Diag.No. : 1694588 Collected on :19/04/2024 01:48:42 PM
IP No. : N/A Received on :19/04/2024 02:02:00 PM
Specimen Type : EDTA PLASMA Reported on :19/04/2024 02:28:46 PM
Ref.Doctor : DR.KIRTHI PALADUGU - ORTHOPAEDIC Location :OPD
SURGERY Report Status :FINAL
HAEMATOLOGY GROUPING
TEST RESULTS
BLOOD GROUPING ABO & RH TYPING
BLOOD GROUPING : 'O'
RH - TYPING : POSITIVE
H - Antigen : POSITIVE

Method: (Conventional Tube Technique)

------------- END OF TEST REPORT ------------

DR.MALATHI.K M.D
Consultant Pathologist

Typed By : LB9100
Yashoda Healthcare Services Pvt.Ltd, Hitec City, Cyber Towers to JNTU Road, Hyderabad, Telangana-500084, www.yashodahospital
Kindly co- relate results with clinical findings. Hitec City

Page 6 of 6